中外医学研究
中外醫學研究
중외의학연구
CHINESE AND FOREIGN MEDICAL RESEARCH
2014年
2期
1-2,3
,共3页
张丽珍%苏秀球%张宝卫%黄笑媚
張麗珍%囌秀毬%張寶衛%黃笑媚
장려진%소수구%장보위%황소미
米非司酮%晚期妊娠%羊水过少%引产
米非司酮%晚期妊娠%羊水過少%引產
미비사동%만기임신%양수과소%인산
Mifepristone%Late pregnancy%Oligohydramnios%Labor induction
目的:探讨米非司酮配合催产素在晚期妊娠引产的可行性。方法:选择笔者所在医院收治的晚期妊娠(即宫内妊娠28周后)有胎儿畸形、胎死宫内、胎膜早破合并胎死宫内羊水过少患者122例,研究组(62例)无论宫颈是否成熟均予米非司酮100 mg单次口服同时予催产素静脉滴注引产,对照组(60例)如宫颈未成熟予普拉睾酮静脉注射同时予催产素静滴引产,宫颈成熟直接予催产素静滴引产。24 h引产未成功研究组重复使用米非司酮100 mg单次口服,对照组宫颈未成熟重复使用普拉睾酮静脉注射,两组继续静脉滴注催产素催产直至胎儿娩出,对比不同宫颈成熟度下两组引产时间、使用催产素总量、产后出血量及软产道损伤情况。结果:两组122例患者均引产成功,宫颈成熟与未成熟两种情况下研究组引产时间、催产素使用量均优于对照组,差异有统计学意义(P<0.05),在宫颈Bishop评分、产后出血及软产道损伤方面,两组比较差异无统计学意义(P>0.05)。结论:米非司酮100 mg口服配合催产素静脉滴注在晚期羊水过少的畸胎及死胎引产,能有效缩短引产时间,不增加产后出血量及软产道的损伤,安全性高,值得基层医院推广应用。
目的:探討米非司酮配閤催產素在晚期妊娠引產的可行性。方法:選擇筆者所在醫院收治的晚期妊娠(即宮內妊娠28週後)有胎兒畸形、胎死宮內、胎膜早破閤併胎死宮內羊水過少患者122例,研究組(62例)無論宮頸是否成熟均予米非司酮100 mg單次口服同時予催產素靜脈滴註引產,對照組(60例)如宮頸未成熟予普拉睪酮靜脈註射同時予催產素靜滴引產,宮頸成熟直接予催產素靜滴引產。24 h引產未成功研究組重複使用米非司酮100 mg單次口服,對照組宮頸未成熟重複使用普拉睪酮靜脈註射,兩組繼續靜脈滴註催產素催產直至胎兒娩齣,對比不同宮頸成熟度下兩組引產時間、使用催產素總量、產後齣血量及軟產道損傷情況。結果:兩組122例患者均引產成功,宮頸成熟與未成熟兩種情況下研究組引產時間、催產素使用量均優于對照組,差異有統計學意義(P<0.05),在宮頸Bishop評分、產後齣血及軟產道損傷方麵,兩組比較差異無統計學意義(P>0.05)。結論:米非司酮100 mg口服配閤催產素靜脈滴註在晚期羊水過少的畸胎及死胎引產,能有效縮短引產時間,不增加產後齣血量及軟產道的損傷,安全性高,值得基層醫院推廣應用。
목적:탐토미비사동배합최산소재만기임신인산적가행성。방법:선택필자소재의원수치적만기임신(즉궁내임신28주후)유태인기형、태사궁내、태막조파합병태사궁내양수과소환자122례,연구조(62례)무론궁경시부성숙균여미비사동100 mg단차구복동시여최산소정맥적주인산,대조조(60례)여궁경미성숙여보랍고동정맥주사동시여최산소정적인산,궁경성숙직접여최산소정적인산。24 h인산미성공연구조중복사용미비사동100 mg단차구복,대조조궁경미성숙중복사용보랍고동정맥주사,량조계속정맥적주최산소최산직지태인면출,대비불동궁경성숙도하량조인산시간、사용최산소총량、산후출혈량급연산도손상정황。결과:량조122례환자균인산성공,궁경성숙여미성숙량충정황하연구조인산시간、최산소사용량균우우대조조,차이유통계학의의(P<0.05),재궁경Bishop평분、산후출혈급연산도손상방면,량조비교차이무통계학의의(P>0.05)。결론:미비사동100 mg구복배합최산소정맥적주재만기양수과소적기태급사태인산,능유효축단인산시간,불증가산후출혈량급연산도적손상,안전성고,치득기층의원추엄응용。
Objective:To investigate the feasibility of mifepristone with oxytocin induction of labor in late pregnancy. Method:Select the author’s hospital treated late pregnancy (intrauterine pregnancy after 28 weeks) with fetal malformation,fetal intrauterine fetal death,premature rupture of membranes merger intrauterine oligohydramnios,122 cases of patients.The reasearch group (62 cases),no matter whether the cervical mature to 100 mg of single oral mifepristone to oxytocin intravenous drip induced labor at the same time,the control group (60 cases),such as cervical prasterone immature to intravenous to oxytocin static drop induced labor at the same time,the cervical mature to oxytocin static drop induced labor directly.24 h induced labor unsuccessful team repeated use 100 mg single oral mifepristone and control group in the cervical prasterone immature reuse intravenous injection,two groups of intravenous drip oxytocin oxytocin until fetal childbirth,compared two groups under different cervical maturity amount induced labor time,use of oxytocin,postpartum blood loss and soft birth canal injury. Result:Two groups of 122 patients were successfully induced labor,cervical mature and immature in both cases the team in induced labor time,oxytocin usage were superior to control group,the difference was statistically significant (P<0.05) in cervical Bishop score,postpartum hemorrhage and soft birth canal injury,the more similar between the two groups had no statistical significance (P>0.05).Conclusion:Mifepristone combined with oxytocin might effectively shorten the labor induction time and improve the efficiency of labor induction without the increasing of the amount of postpartum hemorrhage and soft birth canal injury and be worthy of promotion.